Researchers have genetically altered a mouse to express traits reminiscent of the long-extinct woolly mammoth, including a long, coarsely textured coat, to create the woolly mouse. https://t.co/7wnmoQhN07 @NewsfromScience

Good news for science funding in Europe. Reappointed President von der Leyen says: We will increase our spending..on groundbreaking fundamental research.  To do this, we will expand the European Research Council and the European Innovation Council. https://t.co/BzDd0cSc9l

For 25 years, the Toll-like Receptor pathway was considered a series of distinct protein complexes that drive inflammation. Today, we report that the entire pathway, from receptor to transcription factor, is executed from within one complex—the myddosome. https://t.co/J9xnnt0xXD

Beautiful article by Kristoffer Lottrup in @weekendavisen on the use of #viruses as biological weapons against #cancer and showcasing our recent study published in @NatureComms https://t.co/2Bq4k5oszR

Two in a row for the @DOlagnier Lab ! @demivanderhorst 🇳🇱 successfully defended her PhD work untilted 🦠 Oncolytic virotherapy in Keap1 mutant lung cancer 🫁 at @AarhusUni_int Thanks to the opponents Jonathan Pol and @VanderveenLab for their thorough assessment of the work

After the rain 🌧️ comes the sun ☀️ @AarhusUni @CiViA_Aarhus

Last Wednesday, I had the privilege of being invited to lovely Aarhus by @DOlagnier @AarhusUnito #Biomedicine to attend the PhD defense of Naziia Kurmashev as an 'opponent' (such a strange word for a definitive fan😆) together with @Agbowie1 from @tcddublin .

It is with excitement that I am sharing our new study on oncolytic virotherapy now online in Nature Communications. A huge thank to all collaborators involved on the projects and financial supports including @lundbeckfonden @novonordiskfond @cancer_dk https://t.co/r0T36T689O

Today I am the proud mentor of two outstanding students @demivanderhorst and Naziia Kurmasheva who submitted their PhD thesis on oncolytic #virus #therapy. You did exceptionally well and I now look forward to your defenses

After receiving an ACS Infectious Disease Young Investigator Award in 2021, I am thrilled to join the journal as an Early Career Board Member

Our review on mitochondria and inflammatory diseases is out now. Is a break in the 2 billion year old endosymbiotic relationship with mitochondria a basis for RA, MS, IBD, asthma and more? https://t.co/sFeOCVEmCa https://t.co/Mohche7T3H

Start of an hopefully productive week @CiViA_Aarhus @AarhusUni

SARS-CoV-2 biology and host interactions https://t.co/FbOye5RPli In this Review, @ProfVolkerThiel & colleagues summarize current knowledge of the SARS-CoV-2 intracellular life cycle and the molecular functions of viral proteins, as well as their interaction with the host cell.

📢Very excited about upcoming lecture "How #viruses use their capsid to escape #immune detection and how cells bypass this protection" by Prof Leo James (@JamesLab9 @MRC_LMB) on Fri 9 Feb, 10-11, Biermann lecture theatre,@AarhusUni_int All welcome, please feel free to join!

The OLAGNIER Lab wishes you all a happy 2023 Halloween 🎃 👻 🍂

🔬 Dive into the fascinating world of innate immunity at #TOLL2024! Join us at the forefront of discovery as we explore and challenge the latest breakthroughs. Don't miss the chance to be a part of the advancement, register now. #InnateImmunity 🔗 https://t.co/LGyTUXS5gS

End of the I & I Science Days organized by the department of Biomedicine at Aarhus University Special mention and huge congrats to Maddie for winning the best short oral presentation 🎉 Very proud of this group of talented and motivated researchers 🇩🇰 🇫🇷 🇧🇷 🇬🇧 🇷🇴 🇳🇱 🇷🇺 🇦🇹

Happy Birthday @AarhusUni

Så er vi i gang med årets Networking retreat for Young Academic Leaders. #Grundforsk #dkforsk #dkvid

Dag 2☀️ Into the sandbox: Create posters about your transition to research leader. Networking retreat for Young Academic Leaders. #Grundforsk #dkvid #dkforsk